인플루엔자 신속 진단 검사(RIDT) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the global Rapid Influenza Diagnostic Tests (RIDTs) Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Rapid Influenza Diagnostic Tests Market Size (2025E): US$ 982.0 Mn
• Projected Market Value (2032F): US$ 1,749.5 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 8.6%

Rapid Influenza Diagnostic Tests Market - Report Scope:

The Rapid Influenza Diagnostic Tests (RIDTs) market encompasses diagnostic tools designed to detect influenza viral antigens in respiratory specimens within a short time frame, often under 30 minutes. These tests are crucial in point-of-care settings for timely diagnosis and management of influenza infections, especially during seasonal outbreaks or pandemics. Technological advancements in immunoassays, growing awareness of early disease detection, and increasing global health threats have significantly contributed to the market's momentum.

Market Growth Drivers:

The growth of the global RIDTs market is largely driven by rising incidences of seasonal and pandemic influenza, which has increased the demand for rapid and accurate point-of-care diagnostics. Enhanced public health initiatives and surveillance programs by governments and healthcare agencies have amplified the focus on early detection to curb transmission. In addition, technological innovations in digital and molecular diagnostics, including the development of more sensitive and specific RIDTs, have broadened clinical applications and reliability. The growing adoption of these tests in home care settings and remote healthcare environments further accelerates their market penetration. Moreover, the global increase in geriatric populations, who are at higher risk of severe influenza complications, adds to the demand for faster and convenient diagnostics.

Market Restraints:

Despite strong demand, the RIDTs market faces notable constraints. A key limitation lies in the relatively lower sensitivity of some conventional rapid tests compared to laboratory-based methods such as RT-PCR, leading to false negatives and subsequent challenges in clinical decision-making. This limitation can hinder clinician confidence in test results, especially in critical care scenarios. Additionally, variability in test performance due to mutations in influenza viruses poses challenges to maintaining consistent diagnostic accuracy. Regulatory hurdles and product recalls can also impede market progress, particularly for new entrants aiming to commercialize innovative diagnostics. Moreover, in resource-limited settings, cost constraints and lack of awareness about the benefits of early testing can restrict the widespread adoption of RIDTs.

Market Opportunities:

Amidst these challenges, the RIDTs market presents several lucrative growth opportunities. The increasing integration of molecular diagnostics, particularly NAAT-based rapid tests, offers high sensitivity with reduced turnaround times, positioning them as a preferred alternative in clinical and non-clinical settings. Expansion of telemedicine and decentralized healthcare has opened new channels for home-based influenza testing, supported by user-friendly digital test kits. Emerging economies, particularly in Asia-Pacific and Latin America, offer untapped market potential due to rising healthcare infrastructure investments and growing awareness. Furthermore, strategic collaborations between diagnostic companies and public health organizations can foster innovation and accelerate deployment of next-generation RIDTs. The ongoing focus on pandemic preparedness and investments in infectious disease surveillance also create fertile ground for market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the global RIDTs market's growth?
• Which regions and segments are witnessing the highest adoption of RIDTs?
• How are technological advancements reshaping diagnostic accuracy and speed?
• Who are the leading players in the RIDTs market, and what strategies are they employing to stay competitive?
• What are the emerging trends and market forecasts for the next decade?

Competitive Intelligence and Business Strategy:

Leading players in the global RIDTs market, such as QuidelOrtho Corporation, BD, Abbott, and Thermo Fisher Scientific Inc., are heavily investing in the development of advanced diagnostic platforms with improved sensitivity and faster result delivery. These companies are also focusing on expanding their geographic footprint through mergers, partnerships, and distribution agreements. Innovations such as multiplex assays capable of detecting both influenza A and B simultaneously, and digital diagnostics with smartphone connectivity, are key strategic areas. Other players, including DiaSorin S.p.A., Meridian Life Science, and Virax Biolabs, are enhancing their assay technologies and collaborating with health authorities to bolster public health preparedness. Strengthening presence in home care and remote diagnostics through user-friendly formats continues to be a central strategy for competitive differentiation.

Companies Covered in This Report:

• QuidelOrtho Corporation
• BD
• Thermo Fisher Scientific Inc.
• Abbott
• F. Hoffmann-La Roche Ltd
• DiaSorin S.p.A.
• Meridian Life Science, Inc.
• SEKISUI Diagnostics
• Virax Biolabs
• ACCESS BIO
• Princeton BioMeditech Corporation
• LifeSign LLC.
• McKesson Medical-Surgical Inc.
• Pfizer Inc.

Rapid Influenza Diagnostic Tests Market Segmentation:

By Product Type:

• Conventional
• Digital

By Test Type:

• Influenza A Test
• Influenza B Test
• Influenza A+B Test

By Assay Type:

• Immunochromatographic Assays
• Immunofluorescence Assays
• Nucleic Acid Amplification Test (NAAT)

By Sample Type:

• Throat Swab
• Nasal Swab
• Nasal Aspirate
• Nasopharyngeal Swab
• Nasopharyngeal Aspirate
• Nasopharyngeal Wash

By End User:

• Hospitals & Clinics
• Diagnostic Centers & Laboratories
• Nursing Homes
• Home Care Settings
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Rapid Influenza Diagnostic Tests Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Disease Epidemiology
• 3.3. Technological Advancement
• 3.4. Regulatory Landscape
• 3.5. Value Chain Analysis
• 3.6. Key Deals and Mergers
• 3.7. PESTLE Analysis
• 3.8. Porter's Five Force Analysis

4. Global Rapid Influenza Diagnostic Tests Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 4.3. Global Rapid Influenza Diagnostic Tests Market Outlook: Product Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) and Analysis, By Product Type, 2019-2024
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 4.3.3.1. Conventional
    • 4.3.3.2. Digital
  • 4.3.4. Market Attractiveness Analysis: Product Type
• 4.4. Global Rapid Influenza Diagnostic Tests Market Outlook: Test Type
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
  • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 4.4.3.1. Influenza A Test
    • 4.4.3.2. Influenza B Test
    • 4.4.3.3. Influenza A+B Test
  • 4.4.4. Market Attractiveness Analysis: Test Type
• 4.5. Global Rapid Influenza Diagnostic Tests Market Outlook: Assay Type
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Assay Type, 2019-2024
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
    • 4.5.3.1. Immunochromatographic Assays
    • 4.5.3.2. Immunofluorescence Assays
    • 4.5.3.3. Nucleic Acid Amplification Test (NAAT)
  • 4.5.4. Market Attractiveness Analysis: Assay Type
• 4.6. Global Rapid Influenza Diagnostic Tests Market Outlook: Sample Type
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Sample Type, 2019-2024
  • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
    • 4.6.3.1. Throat Swab
    • 4.6.3.2. Nasal Swab
    • 4.6.3.3. Nasal Aspirate
    • 4.6.3.4. Nasopharyngeal Swab
    • 4.6.3.5. Nasopharyngeal Aspirate
    • 4.6.3.6. Nasopharyngeal Wash
  • 4.6.4. Market Attractiveness Analysis: Sample Type
• 4.7. Global Rapid Influenza Diagnostic Tests Market Outlook: End User
  • 4.7.1. Introduction / Key Findings
  • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 4.7.3.1. Hospitals & Clinics
    • 4.7.3.2. Diagnostic Centers & Laboratories
    • 4.7.3.3. Nursing Homes
    • 4.7.3.4. Home Care Settings
    • 4.7.3.5. Others
  • 4.7.4. Market Attractiveness Analysis: End User

5. Global Rapid Influenza Diagnostic Tests Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Rapid Influenza Diagnostic Tests Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Product Type
  • 6.2.3. By Test Type
  • 6.2.4. By Assay Type
  • 6.2.5. By Sample Type
  • 6.2.6. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 6.4.1. Conventional
  • 6.4.2. Digital
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 6.5.1. Influenza A Test
  • 6.5.2. Influenza B Test
  • 6.5.3. Influenza A+B Test
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
  • 6.6.1. Immunochromatographic Assays
  • 6.6.2. Immunofluorescence Assays
  • 6.6.3. Nucleic Acid Amplification Test (NAAT)
• 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
  • 6.7.1. Throat Swab
  • 6.7.2. Nasal Swab
  • 6.7.3. Nasal Aspirate
  • 6.7.4. Nasopharyngeal Swab
  • 6.7.5. Nasopharyngeal Aspirate
  • 6.7.6. Nasopharyngeal Wash
• 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 6.8.1. Hospitals & Clinics
  • 6.8.2. Diagnostic Centers & Laboratories
  • 6.8.3. Nursing Homes
  • 6.8.4. Home Care Settings
  • 6.8.5. Others
• 6.9. Market Attractiveness Analysis

7. Europe Rapid Influenza Diagnostic Tests Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product Type
  • 7.2.3. By Test Type
  • 7.2.4. By Assay Type
  • 7.2.5. By Sample Type
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 7.4.1. Conventional
  • 7.4.2. Digital
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 7.5.1. Influenza A Test
  • 7.5.2. Influenza B Test
  • 7.5.3. Influenza A+B Test
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
  • 7.6.1. Immunochromatographic Assays
  • 7.6.2. Immunofluorescence Assays
  • 7.6.3. Nucleic Acid Amplification Test (NAAT)
• 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
  • 7.7.1. Throat Swab
  • 7.7.2. Nasal Swab
  • 7.7.3. Nasal Aspirate
  • 7.7.4. Nasopharyngeal Swab
  • 7.7.5. Nasopharyngeal Aspirate
  • 7.7.6. Nasopharyngeal Wash
• 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.8.1. Hospitals & Clinics
  • 7.8.2. Diagnostic Centers & Laboratories
  • 7.8.3. Nursing Homes
  • 7.8.4. Home Care Settings
  • 7.8.5. Others
• 7.9. Market Attractiveness Analysis

8. East Asia Rapid Influenza Diagnostic Tests Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product Type
  • 8.2.3. By Test Type
  • 8.2.4. By Assay Type
  • 8.2.5. By Sample Type
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 8.4.1. Conventional
  • 8.4.2. Digital
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 8.5.1. Influenza A Test
  • 8.5.2. Influenza B Test
  • 8.5.3. Influenza A+B Test
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
  • 8.6.1. Immunochromatographic Assays
  • 8.6.2. Immunofluorescence Assays
  • 8.6.3. Nucleic Acid Amplification Test (NAAT)
• 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
  • 8.7.1. Throat Swab
  • 8.7.2. Nasal Swab
  • 8.7.3. Nasal Aspirate
  • 8.7.4. Nasopharyngeal Swab
  • 8.7.5. Nasopharyngeal Aspirate
  • 8.7.6. Nasopharyngeal Wash
• 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.8.1. Hospitals & Clinics
  • 8.8.2. Diagnostic Centers & Laboratories
  • 8.8.3. Nursing Homes
  • 8.8.4. Home Care Settings
  • 8.8.5. Others
• 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Rapid Influenza Diagnostic Tests Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product Type
  • 9.2.3. By Test Type
  • 9.2.4. By Assay Type
  • 9.2.5. By Sample Type
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 9.4.1. Conventional
  • 9.4.2. Digital
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 9.5.1. Influenza A Test
  • 9.5.2. Influenza B Test
  • 9.5.3. Influenza A+B Test
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
  • 9.6.1. Immunochromatographic Assays
  • 9.6.2. Immunofluorescence Assays
  • 9.6.3. Nucleic Acid Amplification Test (NAAT)
• 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
  • 9.7.1. Throat Swab
  • 9.7.2. Nasal Swab
  • 9.7.3. Nasal Aspirate
  • 9.7.4. Nasopharyngeal Swab
  • 9.7.5. Nasopharyngeal Aspirate
  • 9.7.6. Nasopharyngeal Wash
• 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.8.1. Hospitals & Clinics
  • 9.8.2. Diagnostic Centers & Laboratories
  • 9.8.3. Nursing Homes
  • 9.8.4. Home Care Settings
  • 9.8.5. Others
• 9.9. Market Attractiveness Analysis

10. Latin America Rapid Influenza Diagnostic Tests Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product Type
  • 10.2.3. By Test Type
  • 10.2.4. By Assay Type
  • 10.2.5. By Sample Type
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 10.4.1. Conventional
  • 10.4.2. Digital
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 10.5.1. Influenza A Test
  • 10.5.2. Influenza B Test
  • 10.5.3. Influenza A+B Test
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
  • 10.6.1. Immunochromatographic Assays
  • 10.6.2. Immunofluorescence Assays
  • 10.6.3. Nucleic Acid Amplification Test (NAAT)
• 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
  • 10.7.1. Throat Swab
  • 10.7.2. Nasal Swab
  • 10.7.3. Nasal Aspirate
  • 10.7.4. Nasopharyngeal Swab
  • 10.7.5. Nasopharyngeal Aspirate
  • 10.7.6. Nasopharyngeal Wash
• 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.8.1. Hospitals & Clinics
  • 10.8.2. Diagnostic Centers & Laboratories
  • 10.8.3. Nursing Homes
  • 10.8.4. Home Care Settings
  • 10.8.5. Others
• 10.9. Market Attractiveness Analysis

11. Middle East & Africa Rapid Influenza Diagnostic Tests Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product Type
  • 11.2.3. By Test Type
  • 11.2.4. By Assay Type
  • 11.2.5. By Sample Type
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
  • 11.4.1. Conventional
  • 11.4.2. Digital
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 11.5.1. Influenza A Test
  • 11.5.2. Influenza B Test
  • 11.5.3. Influenza A+B Test
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Assay Type, 2025-2032
  • 11.6.1. Immunochromatographic Assays
  • 11.6.2. Immunofluorescence Assays
  • 11.6.3. Nucleic Acid Amplification Test (NAAT)
• 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Sample Type, 2025-2032
  • 11.7.1. Throat Swab
  • 11.7.2. Nasal Swab
  • 11.7.3. Nasal Aspirate
  • 11.7.4. Nasopharyngeal Swab
  • 11.7.5. Nasopharyngeal Aspirate
  • 11.7.6. Nasopharyngeal Wash
• 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.8.1. Hospitals & Clinics
  • 11.8.2. Diagnostic Centers & Laboratories
  • 11.8.3. Nursing Homes
  • 11.8.4. Home Care Settings
  • 11.8.5. Others
• 11.9. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping by Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. QuidelOrtho Corporation
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Product Type
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. BD
  • 12.3.3. Thermo Fisher Scientific Inc.
  • 12.3.4. Abbott
  • 12.3.5. F. Hoffmann-La Roche Ltd
  • 12.3.6. DiaSorin S.p.A.
  • 12.3.7. Meridian Life Science, Inc.
  • 12.3.8. SEKISUI Diagnostics
  • 12.3.9. Virax Biolabs
  • 12.3.10. ACCESS BIO
  • 12.3.11. Princeton BioMeditech Corporation
  • 12.3.12. LifeSign LLC.
  • 12.3.13. McKesson Medical-Surgical Inc.
  • 12.3.14. Pfizer Inc.
  • 12.3.15. EBOS Healthcare
  • 12.3.16. KANEKA CORPORATION
  • 12.3.17. Siemens Healthcare Private Limited
  • 12.3.18. Healgen
  • 12.3.19. iHealth Labs Inc.
  • 12.3.20. SG Diagnostics
  • 12.3.21. Flowflex UK
  • 12.3.22. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations